ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 263 filers reported holding ACADIA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 1.06 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $201,354 | -12.1% | 12,391 | 0.0% | 0.01% | -12.5% |
| Q1 2024 | $229,109 | -40.9% | 12,391 | 0.0% | 0.01% | -46.7% |
| Q4 2023 | $387,962 | +50.2% | 12,391 | 0.0% | 0.02% | +36.4% |
| Q3 2023 | $258,228 | -16.0% | 12,391 | -3.4% | 0.01% | -15.4% |
| Q2 2023 | $307,255 | +27.3% | 12,829 | 0.0% | 0.01% | +30.0% |
| Q1 2023 | $241,442 | +18.2% | 12,829 | 0.0% | 0.01% | +11.1% |
| Q4 2022 | $204,238 | -4.1% | 12,829 | -1.3% | 0.01% | -18.2% |
| Q3 2022 | $213,000 | +16.4% | 13,000 | 0.0% | 0.01% | +22.2% |
| Q2 2022 | $183,000 | -41.9% | 13,000 | 0.0% | 0.01% | -30.8% |
| Q1 2022 | $315,000 | – | 13,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fairmount Funds Management LLC | 647,833 | $26,723,000 | 11.32% |
| GREAT POINT PARTNERS LLC | 1,921,563 | $79,264,000 | 7.13% |
| Baker Brothers Advisors | 41,904,586 | $1,728,564,000 | 6.91% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 486,000 | $20,048,000 | 6.47% |
| Palo Alto Investors LP | 1,832,300 | $75,582,000 | 4.15% |
| Birchview Capital, LP | 204,000 | $8,416,000 | 2.81% |
| SECTORAL ASSET MANAGEMENT INC | 556,514 | $22,956,000 | 1.97% |
| Rock Springs Capital Management LP | 1,573,200 | $64,895,000 | 1.65% |
| Riggs Asset Managment Co. Inc. | 17,470 | $2,025,000 | 0.85% |
| PFM Health Sciences, LP | 421,087 | $17,370,000 | 0.80% |